(Q45165699)

10 December 2017

title

Toxicity and quality of life outcomes in ovarian cancer patients participating in randomized controlled trials (English)

1 reference

10 December 2017

1 reference

4

Felix Hilpert

1 reference

10 December 2017

Vesna Bjelic-Radisic

2

1 reference

10 December 2017

Jacobus Pfisterer

3

1 reference

10 December 2017

Fedor Daghofer

5

1 reference

10 December 2017

Eric Pujade-Lauraine

6

1 reference

10 December 2017

Andreas du Bois

7

1 reference

10 December 2017

Arbeitsgemeinschaft Gynaekologische Onkologie Ovarian Cancer Study Group (AGO-OVAR)

8

1 reference

10 December 2017

Groupe d'Investigateurs Nationaux pour les Etudes des Cancers de l'Ovaire (GINECO)

9

1 reference

10 December 2017

Elfriede R. Greimel

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20694564

18 June 2024

language of work or name

1 reference

6 August 2010

1 reference

full work available at URL

10 December 2017

http://link.springer.com/content/pdf/10.1007/s00520-010-0969-8.pdf

file format

Portable Document Format

1 reference

DOI

https://api.crossref.org/works/10.1007/S00520-010-0969-8

http://link.springer.com/article/10.1007/s00520-010-0969-8/fulltext.html

18 June 2024

1 reference

https://api.crossref.org/works/10.1007/S00520-010-0969-8

http://link.springer.com/content/pdf/10.1007/s00520-010-0969-8

18 June 2024

1 reference

DOI

https://api.crossref.org/works/10.1007/S00520-010-0969-8

Supportive Care in Cancer

18 June 2024

published in

1 reference

10 December 2017

volume

19

1 reference

10 December 2017

issue

9

1 reference

10 December 2017

page(s)

1421-1427

1 reference

https://scigraph.springernature.com/pub.10.1007/s00520-010-0969-8

10 December 2017

exact match

0 references

cites work

Normal tissue effects: reporting and analysis

1 reference

https://api.crossref.org/works/10.1007%2FS00520-010-0969-8

Patient-reported outcomes and the evolution of adverse event reporting in oncology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-010-0969-8

Symptomatology of cancer patients in palliative care: content validation of self-assessment questionnaires against medical records.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-010-0969-8

Assessing health-related quality of life in palliative care: comparing patient and physician assessments.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-010-0969-8

Patient versus clinician symptom reporting using the National Cancer Institute Common Terminology Criteria for Adverse Events: results of a questionnaire-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-010-0969-8

The need for and characteristics of randomized, phase III trials to evaluate symptom management in patients with cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-010-0969-8

Perception of quality of life by patients, partners and treating physicians.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-010-0969-8

How accurate is clinician reporting of chemotherapy adverse effects? A comparison with patient-reported symptoms from the Quality-of-Life Questionnaire C30.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-010-0969-8

A pooled analysis of quality of life measures and adverse events data in north central cancer treatment group lung cancer clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-010-0969-8

Adverse symptom event reporting by patients vs clinicians: relationships with clinical outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-010-0969-8

The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-010-0969-8

Does QOL provide the same information as toxicity data?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-010-0969-8

A randomized clinical trial of cisplatin/paclitaxel versus carboplatin/paclitaxel as first-line treatment of ovarian cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-010-0969-8

Addition of epirubicin as a third drug to carboplatin-paclitaxel in first-line treatment of advanced ovarian cancer: a prospectively randomized gynecologic cancer intergroup trial by the Arbeitsgemeinschaft Gynaekologische Onkologie Ovarian Cancer S

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-010-0969-8

Randomized phase III trial of topotecan following carboplatin and paclitaxel in first-line treatment of advanced ovarian cancer: a gynecologic cancer intergroup trial of the AGO-OVAR and GINECO.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-010-0969-8

Randomized study of the Arbeitsgemeinschaft Gynaekologische Onkologie Ovarian Cancer Study Group comparing quality of life in patients with ovarian cancer treated with cisplatin/paclitaxel versus carboplatin/paclitaxel.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-010-0969-8

Determining the Relationship Between Toxicity and Quality of Life in an Ovarian Cancer Chemotherapy Clinical Trial

21 January 2018

1 reference

12 December 2020

Palliative effect of chemotherapy: objective tumor response is associated with symptom improvement in patients with metastatic breast cancer

1 reference

12 December 2020

Self-reported quality of life of individual cancer patients: concordance of results with disease course and medical records.

1 reference

12 December 2020

Guidance for industry: patient-reported outcome measures: use in medical product development to support labeling claims: draft guidance

1 reference

12 December 2020

Identifiers

DOI

1 reference

Dimensions Publication ID

10 December 2017

1013887457

0 references

1 reference